Table 3 |
||||
| Causes of death in the hepatitis C group with abnormal transaminase levels | ||||
| IFN treated Group A (n = 152) | SVR Group A1 (n = 72) | Non-SVR Group A2 (n = 80) | No treated Group B (n = 199) | |
| Total deaths | 25 | 9 | 16 | 90 |
| Unknown cause | 0 | 0 | 0 | 1 |
| Liver-related | 6 (24.0%) | 1 (11.1%) | 5 (31.2%) | 32 (36.0%) |
| Others | 19 (76.0%) | 8 (88.9%) | 11 (68.8%) | 57 (64.0%) |
Yamasaki et al. BMC Gastroenterology 2012 12:139 doi:10.1186/1471-230X-12-139
